ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,251, issued on Nov. 18, was assigned to THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (Bethesda, Md.) and UNIVERSITY OF MARYLAND, BALTIMORE (Baltimore).
"Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine" was invented by Craig Thomas (Gaithersburg, Md.), Carlos Zarate (Germantown, Md.), Ruin Moaddel (Bel Air, Md.), Todd Gould (Elkridge, Md.), Panos Zanos (Baltimore) and Patrick Morris (Columbia, Md.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides a method for synthesizing free base foams of (2R,6R)-hydroxynorketamine (H...